Cargo Therapeutics

Cargo Therapeutics is a clinical-stage biotechnology company positioned to advance next-generation, potentially curative cell therapies for cancer patients. CARGO’s programs, platform technologies, and manufacturing strategy are designed to directly address the limitations of approved cell therapies, including limited durability of effect, safety concerns, and unreliable supply.

Learn more at cargo-tx.com